Yazan Abou-Ismail/ LinkedIn
Jun 6, 2026, 23:30
Yazan Abou-Ismail: Insights on A Snail-Derived Potential Anticoagulant with Possibly Improved Bleeding Profile
Yazan Abou-Ismail, Associate Professor of Hematology at the University of Utah, shared on LinkedIn:
”I had the opportunity to share some insights in this Medscape article on a snail-derived (Camaena cicatricose) compound being investigated as a potential novel anticoagulant with possibly improved bleeding profile.
So interesting!
Always great to see the landscape of thrombosis treatment evolve, and the interest in uncoupling thrombosis from hemostasis grow.
I weighed in on potential opportunities and some limitations.
Thank you Beth Rush for putting this together and including me!”
Stay updated with Hemostasis Today.
-
Jun 7, 2026, 03:15Shirley D’Sa: What Comes After BTK Inhibitors in Waldenström Macroglobulinaemia?
-
Jun 6, 2026, 18:40Igor Carvalho de Oliveira: The Hidden Genetic Risk Behind Early Heart Attacks and Strokes
-
Jun 6, 2026, 17:39Kalyan Roy: Immunomodulation after Blood Transfusion
-
Jun 6, 2026, 17:37Intissar Haddiya: Can Low-Dose Rivaroxaban Improve Cardiovascular Outcomes in Patients with Advanced CKD?
-
Jun 6, 2026, 17:34Stanley Anokye: From Microcytes and Macrocytes to Target Cells
-
Jun 6, 2026, 16:53Leonardo Roever: Can a Simple Cholesterol Ratio Predict Post-Stroke Depression?
-
Jun 6, 2026, 16:21Abdulkader Jamal Eddin: ABO Blood Group, COVID-19 and Early Respiratory Outcomes in Acute PE
-
Jun 6, 2026, 15:26Yuying Zhang: Grateful to Present on CD44 as A Potential Plasma-Independent Alternative to IVIG in ITP
-
Jun 6, 2026, 15:16Don Deyo: Breakthrough Therapy for Post-Stroke Upper Limb Impairment Now Published